United States · FDA National Drug Code directory
Revcovi
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10122-502_1b1625bb-25b0-4845-af56-5c06a0715672
- Product NDC
- 10122-502
- Form
- INJECTION
- Composition / generic term
- elapegademase-lvlr
- Labeler
- Chiesi USA, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20181005
- Source listing expiry
- 20271231
Source-listed ingredients
- ELAPEGADEMASE — 1.6 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (10122-502-01) / 1.5 mL in 1 VIAL · 10122-502-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →